Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.11851/3967
Title: A literature review of biosensors for multiple sclerosis: Towards personalized medicine and point-of-care testing
Authors: Can, Demirdöğen Birsen
Keywords: Biomarker
Immunosensor
Lab-on-a-chip
Microfluidic
Nanomaterial
Nanoparticle
Point-of-care testing
Patient-centered healthcare
Personalized medicine
Issue Date: Feb-2021
Publisher: Elsevier B.V.
Source: Demirdöğen, B. C. (2020). A literature review of biosensors for multiple sclerosis: towards personalized medicine and point-of-care testing. Multiple Sclerosis and Related Disorders, 102675.
Abstract: Multiple sclerosis (MS) is a chronic neuroinflammatory disease of the central nervous system that leads to severe motor and sensory deficits in patients. Although some biomolecules in serum or cerebrospinal fluid have been suggested as biomarkers for MS diagnosis, following disease activity and monitoring treatment response, most of these potential biomarkers are not currently in clinical use and available for all patients. The reasons behind this are generally related to insufficient robustness of biomarker or technical difficulties, high prices, and requirements for technical personnel for their detection. Point-of-care testing (POCT) is an emerging field of healthcare that can be applied at the hospital as well as at home without the need for a centralized laboratory. Biosensor devices offer a convenient means for POCT. A biosensor is a compact analytical device that uses a bioreceptor, such as an antibody, enzyme, or oligonucleotide, to capture the analyte of interest. The interaction between the analyte and the bioreceptor is sensed and transduced into a suitable signal by the signal transducer. The advantages of using a biosensor for detecting the biomolecule of interest include speed, simplicity, accuracy, relatively lower cost, and lack of requirements for highly qualified personnel to perform the testing. Owing to these advantages and with the help of innovations in biosensor development technologies, there has been a great interest in developing biosensor devices for MS in recent years. Hence, the purpose of this review was to provide researchers with an up-to-date summary of the literature as well as to highlight the challenges and opportunities in this translational research field. In addition, because this is a highly interdisciplinary field of study, potentially concerning MS specialists, neurologists, biomedical researchers, and engineers, another aim of this review was to bridge the gap between these disciplines.
URI: https://hdl.handle.net/20.500.11851/3967
https://doi.org/10.1016/j.msard.2020.102675
ISSN: 2211-0348
Appears in Collections:Biyomedikal Mühendisliği Bölümü / Department of Biomedical Engineering
PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Show full item record

CORE Recommender

WEB OF SCIENCETM
Citations

2
checked on Sep 24, 2022

Page view(s)

86
checked on Dec 26, 2022

Google ScholarTM

Check

Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.